NCT05544721
A Study of Paravertebral Block in Thoracic Outlet Syndrome
Enrolling by Invitation
PHASE4Ages 18+InterventionalSupportive careMayo ClinicInvestigator-initiated
~50 participants
Updated 2025-11-14 on ClinicalTrials.gov
What's tested:Ropivacaine
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in pain level
Measured over Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Houssam Farres, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
Patients who are pregnant.
Patients with prior first rib resection on side of presentation.
Patients with complex regional pain syndrome (CRPS).
Patients with brachial plexus disorder.
Patients with cervical rib.
What this trial measures
- Change in pain levelTime of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op
Measured using the pain visual analog scale (VAS). The VAS line will be 100 mm long with each end marked with "no pain" on the left, and "worst possible pain" on the right; participant identify their pain level by indicating a point on the line between each end and this point is measured from the "No pain" end, and the number of millimeters is reported as the pain score.